A nurse is teaching a group of women about medications. The women want to know why so many drugs have unpredictable effects in women. The nurse will tell them that:
Drugs usually have more toxic effects in women.
Women metabolize drugs more slowly.
Most known drug effects are based on drug trials in men.
Women have varying responses to drugs during menstrual cycles.
The Correct Answer is C
Choice A Reason:
While it is true that women often experience more adverse drug reactions than men, this is not because drugs inherently have more toxic effects in women. The higher incidence of side effects in women is largely due to the fact that drug dosages and effects have historically been studied primarily in men. This has led to a lack of understanding of how drugs specifically affect women.
Choice B Reason:
Women do not necessarily metabolize drugs more slowly than men. Drug metabolism can vary widely depending on the specific medication and individual differences. However, the lack of female representation in clinical trials has resulted in less data on how women metabolize certain drugs, leading to unpredictable effects.
Choice C Reason:
Most known drug effects are indeed based on drug trials conducted predominantly in men. Historically, women were excluded from clinical trials due to concerns about hormonal fluctuations and potential risks to fetuses. This has resulted in a significant gap in knowledge about how drugs affect women, leading to more unpredictable and often adverse effects when these drugs are used by women.
Choice D Reason:
While hormonal fluctuations during menstrual cycles can affect drug metabolism and efficacy, this is not the primary reason for the unpredictable effects of drugs in women. The main issue is the historical exclusion of women from clinical trials, which has led to a lack of data on how drugs affect women differently from men.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is B
Explanation
Choice A Reason:
Inducer medications do not increase the blood level of newly added medications. Instead, they enhance the activity of enzymes that metabolize drugs, leading to a faster breakdown and lower concentration of the new medication in the bloodstream. This can result in reduced efficacy of the newly added medication.
Choice B Reason:
Inducer medications increase the activity of enzymes, particularly those in the cytochrome P450 family, which are responsible for drug metabolism. This increased enzyme activity accelerates the breakdown of the newly added medication, thereby decreasing its blood level and potentially reducing its therapeutic effect. For example, rifampin is a well-known inducer that can significantly lower the levels of drugs metabolized by CYP3A4.
Choice C Reason:
Inducer medications do not increase the half-life of newly added medications. On the contrary, by enhancing the metabolic activity of enzymes, they typically reduce the half-life of the new medication. This means the drug is broken down and eliminated from the body more quickly.
Choice D Reason:
Inducer medications do have a significant effect on new medications. They alter the metabolism of drugs by increasing the activity of metabolic enzymes, which can lead to decreased blood levels and reduced effectiveness of the new medication. Ignoring this interaction can result in subtherapeutic drug levels and treatment failure.
Correct Answer is C
Explanation
Choice A Reason:
Beta2 agonists, such as terbutaline, are commonly used to manage premature labor. These drugs work by stimulating beta2 adrenergic receptors in the smooth muscles of the uterus, leading to relaxation and suppression of contractions. Therefore, questioning the use of a beta2 agonist in this scenario would not be appropriate.
Choice B Reason:
Anticholinergic drugs are not typically used to manage premature labor. They work by blocking the action of acetylcholine in the nervous system, which can lead to various effects such as reduced secretions and relaxation of smooth muscles. However, they are not specifically indicated for stopping uterine contractions, so questioning their use in this context is less relevant.
Choice C Reason:
This is the correct answer. Beta2 antagonists, also known as beta-blockers, work by blocking beta2 adrenergic receptors, which can lead to increased uterine contractions. Using a beta2 antagonist in a patient experiencing premature labor would be counterproductive and could exacerbate the condition. Therefore, it is appropriate to question the use of beta2 antagonists in this scenario.
Choice D Reason:
Alpha1 agonists are not typically used in the management of premature labor. These drugs stimulate alpha1 adrenergic receptors, leading to vasoconstriction and increased blood pressure. They do not have a direct effect on uterine contractions, so questioning their use in this context is less relevant.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.